Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lamb–Shaffer syndrome: 20 Spanish patients and literature review expands the view of neurodevelopmental disorders caused by SOX5 haploinsufficiency

  • Tenorio-Castaño, Jair Antonio
  • Gómez, Á.S.A.
  • Coronado, M.
  • Rodríguez-Martín, Pilar
  • Parra, A.
  • Pascual, P.
  • Cazalla, M.
  • Gallego, Natalia
  • Arias, Pedro
  • Morales, Aixa V.
  • Nevado, Julian
  • Lapunzina, Pablo
Lamb–Shaffer Syndrome (LSS; OMIM #616803; ORPHA #313892; ORPHA #313884) is an infrequent genetic disorder that affects multiple aspects of human development especially those related to the development of the nervous system. LSS is caused by variants in the SOX5 gene. At the molecular level, SOX5 gene encodes for a transcription factor containing a High Mobility Group (HMG) DNA-Binding domain with relevant functions in brain development in different vertebrate species. Clinical features of Lamb–Shaffer syndrome may include intellectual disability, delayed speech and language development, attention deficits, hyperactivity, autism spectrum disorder, visual problems and seizures. Additionally, patients with the syndrome may present distinct facial dimorphism such as a wide mouth with full lips, small chin, broad nasal bridge, and deep-set eyes. Other physical features that have been reported in some patients include short stature, scoliosis, and joint hypermobility. Here, we report the clinical and molecular characterization of a Spanish LSS cohort of new 20 patients and review all the patients published so far which amount for 111 patients. The most frequent features included developmental delay, intellectual disability, visual problems, poor speech development and facial dysmorphic features. Strikingly, pain insensitivity and hypermetropia seems to be more frequent than previously reported, based on the frequency seen in the Spanish cohort. Eighty-three variants have been reported so far, single nucleotide variants (SNV) and copy number variants represent 47% and 53%, respectively, from the total of variants reported. Similarly to previous reports, the majority of the SNVs variants of the novel patients reported herein fall in the HMG domain of the protein. However, new variants, affecting other functional domains, were also detected. In conclusion, LLS is a rare genetic disorder mostly characterized by a wide range of developmental and neurological symptoms. Early diagnosis would allow to start of care programs, clinical follow up, prospective studies and appropriate genetic counseling, to promote clinical and social improvement to have profound lifelong benefits for patients and their families. Further research is needed to better understand the underlying mechanisms of the syndrome related to SOX5 haploinsufficiency., European Regional Development Fund;Instituto de Salud Carlos III, Grant/AwardNumbers: PI20/01053, PMP22/00049,PMP21/00063, Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Snijders Blok–Campeau Syndrome: Description of 20 additional individuals with variants in CHD3 and literature review

  • Pascual, Patricia
  • Tenorio-Castano, Jair
  • Mignot, Cyril
  • Afenjar, Alexandra
  • Arias, Pedro
  • Gallego-Zazo, Natalia
  • Parra, Alejandro
  • Miranda, Lucia
  • Cazalla, Mario
  • Silván, Cristina
  • Heron, Delphine
  • Keren, Boris
  • Popa, Ioana
  • Palomares, María
  • Rikeros, Emi
  • Ramos, Feliciano J.
  • Almoguera, Berta
  • Ayuso, Carmen
  • Swafiri, Saoud Tahsin
  • Barbero, Ana Isabel Sánchez
  • Srinivasan, Varunvenkat M.
  • Gowda, Vykuntaraju K.
  • Morleo, Manuela
  • Nigro, Vicenzo
  • D’Arrigo, Stefano
  • Ciaccio, Claudia
  • Martin Mesa, Carmen
  • Paumard, Beatriz
  • Guillen, Gema
  • Anton, Ana Teresa Serrano
  • Jimenez, Marta Domínguez
  • Seidel, Veronica
  • Suárez, Julia
  • Cormier-Daire, Valerie
  • Consortium, The SOGRI
  • Nevado, Julián
  • Lapunzina, Pablo
Snijders Blok–Campeau syndrome (SNIBCPS, OMIM# 618205) is an extremely infrequent disease with only approximately 60 cases reported so far. SNIBCPS belongs to the group of neurodevelopmental disorders (NDDs). Clinical features of patients with SNIBCPS include global developmental delay, intellectual disability, speech and language difficulties and behavioral disorders like autism spectrum disorder. In addition, patients with SNIBCPS exhibit typical dysmorphic features including macrocephaly, hypertelorism, sparse eyebrows, broad forehead, prominent nose and pointed chin. The severity of the neurological effects as well as the presence of other features is variable among subjects. SNIBCPS is caused likely by pathogenic and pathogenic variants in CHD3 (Chromodomain Helicase DNA Binding Protein 3), which seems to be involved in chromatin remodeling by deacetylating histones. Here, we report 20 additional patients with clinical features compatible with SNIBCPS from 17 unrelated families with confirmed likely pathogenic/pathogenic variants in CHD3. Patients were analyzed by whole exome sequencing and segregation studies were performed by Sanger sequencing. Patients in this study showed different pathogenic variants affecting several functional domains of the protein. Additionally, none of the variants described here were reported in control population databases, and most computational predictors suggest that they are deleterious. The most common clinical features of the whole cohort of patients are global developmental delay (98%) and speech disorder/delay (92%). Other frequent features (51–74%) include intellectual disability, hypotonia, hypertelorism, abnormality of vision, macrocephaly and prominent forehead, among others. This study expands the number of individuals with confirmed SNIBCPS due to pathogenic or likely pathogenic variants in CHD3. Furthermore, we add evidence of the importance of the application of massive parallel sequencing for NDD patients for whom the clinical diagnosis might be challenging and where deep phenotyping is extremely useful to accurately manage and follow up the patients.